Logo image of CEMX.CA

CEMATRIX CORP (CEMX.CA) Stock Fundamental Analysis

TSX:CEMX - Toronto Stock Exchange - CA15120R1038 - Common Stock - Currency: CAD

0.315  0 (0%)

Fundamental Rating

3

Overall CEMX gets a fundamental rating of 3 out of 10. We evaluated CEMX against 3 industry peers in the Construction Materials industry. While CEMX seems to be doing ok healthwise, there are quite some concerns on its profitability. CEMX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CEMX has reported negative net income.
CEMX had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CEMX reported negative net income in multiple years.
In multiple years CEMX reported negative operating cash flow during the last 5 years.
CEMX.CA Yearly Net Income VS EBIT VS OCF VS FCFCEMX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M

1.2 Ratios

CEMX's Return On Assets of -2.32% is on the low side compared to the rest of the industry. CEMX is outperformed by 66.67% of its industry peers.
CEMX has a worse Return On Equity (-2.68%) than 66.67% of its industry peers.
Industry RankSector Rank
ROA -2.32%
ROE -2.68%
ROIC N/A
ROA(3y)-3.29%
ROA(5y)-9.59%
ROE(3y)-5.01%
ROE(5y)-291.97%
ROIC(3y)N/A
ROIC(5y)N/A
CEMX.CA Yearly ROA, ROE, ROICCEMX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

Looking at the Gross Margin, with a value of 24.75%, CEMX is doing worse than 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of CEMX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for CEMX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.58%
GM growth 5Y0.78%
CEMX.CA Yearly Profit, Operating, Gross MarginsCEMX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

5

2. Health

2.1 Basic Checks

CEMX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CEMX has been increased compared to 1 year ago.
The number of shares outstanding for CEMX has been increased compared to 5 years ago.
The debt/assets ratio for CEMX has remained at the same level compared to a year ago.
CEMX.CA Yearly Shares OutstandingCEMX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CEMX.CA Yearly Total Debt VS Total AssetsCEMX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

CEMX has an Altman-Z score of 5.39. This indicates that CEMX is financially healthy and has little risk of bankruptcy at the moment.
With a Altman-Z score value of 5.39, CEMX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
CEMX has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.08, CEMX is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 5.39
ROIC/WACCN/A
WACC9.17%
CEMX.CA Yearly LT Debt VS Equity VS FCFCEMX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

CEMX has a Current Ratio of 8.18. This indicates that CEMX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.18, CEMX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CEMX has a Quick Ratio of 7.85. This indicates that CEMX is financially healthy and has no problem in meeting its short term obligations.
CEMX's Quick ratio of 7.85 is amongst the best of the industry. CEMX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 8.18
Quick Ratio 7.85
CEMX.CA Yearly Current Assets VS Current LiabilitesCEMX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for CEMX have decreased strongly by -134.06% in the last year.
The Revenue for CEMX has decreased by -38.50% in the past year. This is quite bad
The Revenue has been growing by 9.42% on average over the past years. This is quite good.
EPS 1Y (TTM)-134.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-340%
Revenue 1Y (TTM)-38.5%
Revenue growth 3Y16.09%
Revenue growth 5Y9.42%
Sales Q2Q%-21.46%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year85.43%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CEMX.CA Yearly Revenue VS EstimatesCEMX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CEMX.CA Yearly EPS VS EstimatesCEMX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0 0.02 -0.02 0.04 -0.04

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

CEMX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 7.72, which indicates a rather cheap valuation of CEMX.
Based on the Price/Forward Earnings ratio, CEMX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CEMX to the average of the S&P500 Index (21.90), we can say CEMX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 7.72
CEMX.CA Price Earnings VS Forward Price EarningsCEMX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 -30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CEMX is valued a bit more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.8
CEMX.CA Per share dataCEMX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15 0.2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CEMX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CEMATRIX CORP

TSX:CEMX (7/4/2025, 7:00:00 PM)

0.315

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)05-07 2025-05-07
Earnings (Next)08-05 2025-08-05
Inst Owners0.59%
Inst Owner ChangeN/A
Ins Owners10.18%
Ins Owner ChangeN/A
Market Cap47.54M
Analysts82.86
Price Target0.36 (14.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-54.84%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.72
P/S 1.42
P/FCF N/A
P/OCF N/A
P/B 1.29
P/tB 1.57
EV/EBITDA 24.8
EPS(TTM)-0.01
EYN/A
EPS(NY)0.04
Fwd EY12.95%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.22
BVpS0.24
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.32%
ROE -2.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.75%
FCFM N/A
ROA(3y)-3.29%
ROA(5y)-9.59%
ROE(3y)-5.01%
ROE(5y)-291.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.58%
GM growth 5Y0.78%
F-Score1
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 1.8
Cap/Depr 102.07%
Cap/Sales 6.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.18
Quick Ratio 7.85
Altman-Z 5.39
F-Score1
WACC9.17%
ROIC/WACCN/A
Cap/Depr(3y)93.01%
Cap/Depr(5y)62.17%
Cap/Sales(3y)5.27%
Cap/Sales(5y)3.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-134.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-340%
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-38.5%
Revenue growth 3Y16.09%
Revenue growth 5Y9.42%
Sales Q2Q%-21.46%
Revenue Next Year85.43%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-112.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year152.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.83%
FCF growth 3YN/A
FCF growth 5Y77.21%
OCF growth 1Y42.95%
OCF growth 3YN/A
OCF growth 5Y41%